231 related articles for article (PubMed ID: 1709251)
21. The diagnostic value of serum lysozyme activity in inflammatory bowel disease.
Ayulo JA; Chen CC; Pelot D; Berk JE
Am J Gastroenterol; 1977 Jul; 68(1):71-6. PubMed ID: 910787
[TBL] [Abstract][Full Text] [Related]
22. Increased incidence of azathioprine-induced pancreatitis in Crohn's disease compared with other diseases.
Weersma RK; Peters FT; Oostenbrug LE; van den Berg AP; van Haastert M; Ploeg RJ; Posthumus MD; Homan van der Heide JJ; Jansen PL; van Dullemen HM
Aliment Pharmacol Ther; 2004 Oct; 20(8):843-50. PubMed ID: 15479355
[TBL] [Abstract][Full Text] [Related]
23. [Crohn disease-associated pancreatitis: is there a new extra-intestinal manifestation of the disease?].
Tromm A; Respondek M; Schwegler U; Kuntz HD; May B
Z Gastroenterol; 1990 Apr; 28(4):208-10. PubMed ID: 2119092
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996.
Torres EA; De Jesús R; Pérez CM; Iñesta M; Torres D; Morell C; Just E
P R Health Sci J; 2003 Sep; 22(3):253-8. PubMed ID: 14619451
[TBL] [Abstract][Full Text] [Related]
25. Pancreatitis in patients with chronic inflammatory bowel disease.
Niemelä S; Lehtola J; Karttunen T; Lähde S
Hepatogastroenterology; 1989 Jun; 36(3):175-7. PubMed ID: 2753464
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic yield of capsule endoscopy in ulcerative colitis and inflammatory bowel disease of unclassified type (IBDU).
Mehdizadeh S; Chen G; Enayati PJ; Cheng DW; Han NJ; Shaye OA; Ippoliti A; Vasiliauskas EA; Lo SK; Papadakis KA
Endoscopy; 2008 Jan; 40(1):30-5. PubMed ID: 18058654
[TBL] [Abstract][Full Text] [Related]
27. [Familial prevalence in chronic intestinal inflammatory disease. Differences among groups of patients with and without a familial history].
Nos P; Argüello L; Hoyos M; Ramírez JJ; Hinojosa J; Molés JR; García A; Berenguer M; Berenguer J
Rev Esp Enferm Dig; 1996 Jul; 88(7):470-4. PubMed ID: 8924324
[TBL] [Abstract][Full Text] [Related]
28. Frequency and clinical evolution of indeterminate colitis: a retrospective multi-centre study in northern Italy. GSMII (Gruppo di Studio per le Malattie Infiammatorie Intestinali).
Meucci G; Bortoli A; Riccioli FA; Girelli CM; Radaelli F; Rivolta R; Tatarella M
Eur J Gastroenterol Hepatol; 1999 Aug; 11(8):909-13. PubMed ID: 10514127
[TBL] [Abstract][Full Text] [Related]
29. Inflammatory bowel diseases, 5-aminosalicylic acid and sulfasalazine treatment and risk of acute pancreatitis: a population-based case-control study.
Munk EM; Pedersen L; Floyd A; Nørgård B; Rasmussen HH; Sørensen HT
Am J Gastroenterol; 2004 May; 99(5):884-8. PubMed ID: 15128355
[TBL] [Abstract][Full Text] [Related]
30. Are pancreatic autoantibodies associated with azathioprine-induced pancreatitis in Crohn's disease?
Weersma RK; Batstra MR; Kleibeuker JH; van Dullemen HM
JOP; 2008 May; 9(3):283-9. PubMed ID: 18469440
[TBL] [Abstract][Full Text] [Related]
31. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
Niederau C; Backmerhoff F; Schumacher B; Niederau C
Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126
[TBL] [Abstract][Full Text] [Related]
32. The hourly rate of urinary amylase excretion, serum amylase, and serum lipase. II. Patients with gastrointestinal and pancreatic disorders.
Waller SL; Ralston AJ
Gut; 1971 Nov; 12(11):884-90. PubMed ID: 5132218
[TBL] [Abstract][Full Text] [Related]
33. Acute pancreatitis after azathioprine treatment for ulcerative colitis.
Tragnone A; Bazzocchi G; Aversa G; Pecorelli MG; Elmi G; Venerato S; Lanfranchi GA
Ital J Gastroenterol; 1996; 28(2):102-4. PubMed ID: 8782004
[TBL] [Abstract][Full Text] [Related]
34. Inflammatory bowel disease in Kuwait.
Al-Nakib B; Radhakrishnan S; Jacob GS; Al-Liddawi H; Al-Ruwaih A
Am J Gastroenterol; 1984 Mar; 79(3):191-4. PubMed ID: 6702804
[TBL] [Abstract][Full Text] [Related]
35. [Significance of immunoreactive lipase in the diagnosis of pancreatic diseases].
Kehl O; Bühler H; Münch R; Pei P; Ammann RW
Schweiz Med Wochenschr; 1985 Aug; 115(33):1135-9. PubMed ID: 2412282
[TBL] [Abstract][Full Text] [Related]
36. Serum angiotensin converting enzyme activity in Crohn's disease and ulcerative colitis.
Letizia C; D'Ambrosio C; Agostini D; Corsi A; Boirivant M; Pallone F; Scavo D
Ital J Gastroenterol; 1993 Jan; 25(1):23-5. PubMed ID: 8381313
[TBL] [Abstract][Full Text] [Related]
37. [The usefulness of reactive protein C in managing patients with ulcerative colitis and Crohn's disease].
López Morante AJ; Sáez-Royuela F; Yuguero del Moral L; Martín Lorente JL; Ojeda Giménez C
Rev Esp Enferm Dig; 1993 Jan; 83(1):5-9. PubMed ID: 8452705
[TBL] [Abstract][Full Text] [Related]
38. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
Roblin X; Serre-Debeauvais F; Phelip JM; Faucheron JL; Hardy G; Chartier A; Helluwaert F; Bessard G; Bonaz B
Aliment Pharmacol Ther; 2005 Apr; 21(7):829-39. PubMed ID: 15801918
[TBL] [Abstract][Full Text] [Related]
39. Focally enhanced gastritis in children with Crohn's disease and ulcerative colitis.
Sharif F; McDermott M; Dillon M; Drumm B; Rowland M; Imrie C; Kelleher S; Harty S; Bourke B
Am J Gastroenterol; 2002 Jun; 97(6):1415-20. PubMed ID: 12094859
[TBL] [Abstract][Full Text] [Related]
40. Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus.
Bourreille A; Ignjatovic A; Aabakken L; Loftus EV; Eliakim R; Pennazio M; Bouhnik Y; Seidman E; Keuchel M; Albert JG; Ardizzone S; Bar-Meir S; Bisschops R; Despott EJ; Fortun PF; Heuschkel R; Kammermeier J; Leighton JA; Mantzaris GJ; Moussata D; Lo S; Paulsen V; Panés J; Radford-Smith G; Reinisch W; Rondonotti E; Sanders DS; Swoger JM; Yamamoto H; Travis S; Colombel JF; Van Gossum A;
Endoscopy; 2009 Jul; 41(7):618-37. PubMed ID: 19588292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]